home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

13 rows where docket_id = "FDA-2025-P-6094" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 2

  • 2025 11
  • 2026 2

document_type 2

  • Supporting & Related Material 9
  • Other 4

agency_id 1

  • FDA 13
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-P-6094-0013 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Interim Response Other Letter(s) 2026-05-12T04:00:00Z 2026 5 2026-05-12T04:00:00Z   2026-05-12T18:33:39Z   0 0 09000064b92cf88c
FDA-2025-P-6094-0012 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 SSRI listening session minutes_3-24-26 Other Memorandum 2026-04-24T04:00:00Z 2026 4 2026-04-24T04:00:00Z   2026-04-24T18:28:27Z   0 0 09000064b92a5f88
FDA-2025-P-6094-0005 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 3 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:15Z   0 0 09000064b908414f
FDA-2025-P-6094-0008 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 6 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:33Z   0 0 09000064b9086066
FDA-2025-P-6094-0004 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 2 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:10Z   0 0 09000064b908414e
FDA-2025-P-6094-0006 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 4 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:20Z   0 0 09000064b9086064
FDA-2025-P-6094-0003 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 1 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:05Z   0 0 09000064b908414d
FDA-2025-P-6094-0007 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 5 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:27Z   0 0 09000064b9086065
FDA-2025-P-6094-0010 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 8 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:47Z   0 0 09000064b9086068
FDA-2025-P-6094-0001 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Citizen Petition from Public Citizen's Health Research Group Other Citizen Petition 2025-11-17T05:00:00Z 2025 11 2025-11-17T05:00:00Z   2025-11-18T01:07:07Z   1 0 09000064b9086491
FDA-2025-P-6094-0009 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 7 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:40Z   0 0 09000064b9086067
FDA-2025-P-6094-0002 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Acknowledgement Letter from FDA DMB to Public Citizen's Health Research Group Other Acknowledgement Letter/Receipt 2025-11-17T05:00:00Z 2025 11 2025-11-17T05:00:00Z   2025-11-18T01:07:13Z   0 0 09000064b9086493
FDA-2025-P-6094-0011 FDA Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. FDA-2025-P-6094 Sources – Part 9 Supporting & Related Material Background Material 2025-11-17T05:00:00Z 2025 11     2025-11-18T02:12:53Z   0 0 09000064b9086069

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 8.163ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API